MarketCap
Facebook
X
TelegramQuarterly report 2022-Q1
added 05-16-2026
Natus Medical Incorporated Total Liabilities 2011-2026 | NTUS
Annual Total Liabilities Natus Medical Incorporated
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 140 M | 189 M | 206 M | 240 M | 288 M | 232 M | 88.8 M | 82.1 M | 121 M | 123 M | 56.5 M | 67 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 288 M | 56.5 M | 153 M |
Quarterly Total Liabilities Natus Medical Incorporated
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 137 M | 140 M | 139 M | 138 M | 172 M | 189 M | 201 M | 225 M | 249 M | 206 M | 223 M | 226 M | 271 M | 240 M | 244 M | 256 M | 266 M | 288 M | 279 M | 236 M | 268 M | 232 M | 101 M | 89.9 M | 80.4 M | 88.8 M | 89.1 M | 80.1 M | 85.2 M | 82.1 M | 83.1 M | 89.3 M | 109 M | 121 M | 127 M | 125 M | 135 M | 123 M | 129 M | 89 M | 56.3 M | 56.5 M | 56.3 M | 58.5 M | 56.6 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 288 M | 56.3 M | 154 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
82.4 M | - | - | $ 3.31 B | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
69.7 M | $ 11.63 | 3.84 % | $ 329 M | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
126 M | $ 8.19 | -0.67 % | $ 1.23 B | USA |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
45.2 M | $ 4.42 | 4.0 % | $ 165 M |  France |
 |
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
LivaNova PLC
LIVN
|
1.41 B | $ 73.84 | 0.18 % | $ 4.03 B |  Britain |
 |
LENSAR
LNSR
|
83.7 M | $ 5.98 | 1.7 % | $ 71.5 M | USA |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.02 M | $ 2.33 | 0.87 % | $ 51.4 M | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.45 | -3.38 % | $ 28 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 18.45 | -0.3 % | $ 433 M | USA |
 |
Delcath Systems
DCTH
|
12.4 M | $ 11.41 | 1.6 % | $ 409 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Profound Medical Corp.
PROF
|
11 M | $ 6.93 | 0.18 % | $ 210 M | Canada |
 |
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.01 | 1.0 % | $ 17.1 M | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | USA |
 |
MiMedx Group
MDXG
|
86.1 M | $ 3.64 | -4.09 % | $ 538 M | USA |
 |
Pulmonx Corporation
LUNG
|
75.2 M | $ 1.55 | 0.32 % | $ 63.1 M | USA |
 |
Electromed
ELMD
|
10.6 M | $ 38.67 | 2.46 % | $ 327 M | USA |
 |
Myomo
MYO
|
27.2 M | $ 0.94 | 2.32 % | $ 39.3 M | USA |
 |
Butterfly Network
BFLY
|
101 M | $ 4.49 | 2.05 % | $ 1.11 B | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Sintx Technologies
SINT
|
6.58 M | $ 2.26 | 2.04 % | $ 6.27 M | USA |
 |
Orthofix Medical
OFIX
|
401 M | $ 10.09 | -16.95 % | $ 400 M |  Curacao |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
730 M | $ 84.17 | 0.19 % | $ 11.4 B | USA |
 |
Insulet Corporation
PODD
|
1.68 B | $ 157.39 | 0.51 % | $ 11.1 B | USA |
 |
TransMedics Group
TMDX
|
595 M | $ 69.01 | 1.48 % | $ 2.35 B | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 37.18 | 0.42 % | $ 1.15 B | USA |
 |
Inspire Medical Systems
INSP
|
126 M | $ 44.57 | 0.95 % | $ 1.31 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.66 B | $ 90.03 | -1.53 % | $ 3.13 B | USA |
 |
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 83.3 | 0.37 % | $ 48.7 B | USA |